Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HDSN vs ABI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HDSN Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

HDSN Overall Winner 6-Pillar Tally: HDSN 6 – 0 ABI Matrix Metrics: HDSN 8 – 2 ABI

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) is the stronger overall head-to-head candidate over ABI (ABI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HDSN carries a Unified Composite Score of 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin), whereas ABI carries 52.7/100 (HOLD) at $24.46 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile ABI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 37.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HDSN vs ABI
HDSN NASDAQ Head-to-Head Winner
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99
ABI US Equity
ABI
Institutional Equity
$24.46
-0.08% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 2% Vol
Unified Composite Score
52.7 / 100 HOLD
Tech 64.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.4%) with fading momentum, RSI 37
RSI-14: 37.0 · SMA20: $24.55 · SMA50: $24.55

6-Pillar Scorecard Institutional Category Breakdown (HDSN 6 – 0 ABI)

Columns: Metric · HDSN · ABI
1. Valuation Multiples HDSN
Forward P/E 25.9x N/M
Trailing P/E 16.5x N/M
PEG Ratio 0.29x N/M
EV / Revenue 0.6x N/M
2. Growth & Scale HDSN
Revenue Growth (YoY) -19.7% N/A
Earnings Growth (YoY) -82.0% N/A
TTM Revenue (USD) $242M N/A
Market Cap $186.5M N/A
3. Profitability & Quality HDSN
Gross Margin 21.0% N/A
Operating Margin 2.0% N/A
Net Profit Margin -0.5% N/A
Return on Equity (ROE) -0.5% N/A
4. Balance Sheet & Cash Flow HDSN
Cash Generation (TTM) -$32M N/A
Cash Flow Margin -13.0% N/A
Net Cash / Leverage $31M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HDSN
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 79.1% (15th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat HDSN
OpEx & R&D Intensity 19.0% of Rev ($46M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HDSN (8) vs ABI (2)
Institutional Metric HDSN ABI Criterion Row Edge
Market Capitalization
Scale
$186.5M N/A Larger Scale HDSN
Trailing P/E Ratio
Valuation
16.5x N/M Lower Multiple HDSN
Forward P/E Ratio
Valuation
25.9x N/M Lower Multiple HDSN
Revenue Growth (YoY)
Growth
-19.7% N/A Higher Growth HDSN
Operating Margin (TTM)
Profitability
2.0% N/A Higher Margin HDSN
Net Profit Margin
Profitability
-0.5% N/A Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
-0.5% N/A Higher ROE HDSN
52-Week Range Position
Momentum
6% ($4–$8) 14% ($24–$25) Stronger Trend ABI
Beta / 30D Volatility
Risk Regime
1.32β · 68% Vol 0.02β · 2% Vol Lower Realized Risk ABI
Unified Institutional Score
Composite Signal
53.2 / 100 (HOLD) 52.7 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$242M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
21.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.29x PEG · 0.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$32M ($31M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABI +15.11 pp
HDSN: -15.27% · ABI: -0.16%
3M Horizon ABI +23.32 pp
HDSN: -24.67% · ABI: -1.35%
6M Horizon ABI +12.85 pp
HDSN: -14.24% · ABI: -1.39%
1Y Horizon ABI +36.41 pp
HDSN: -38.12% · ABI: -1.71%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HDSN vs ABI. Trailing 12-month operating profitability (HDSN 2.0% vs ABI N/A) and valuation multiples (HDSN 25.9x vs ABI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

HDSN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$242M
Gross Margin21.0%
Op. Margin2.0%
ROE / Fwd P/E-0.5% · 25.9x
ABI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published
ABI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ HDSN vs ABI Key Questions & Quantitative Answers

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) is the stronger overall head-to-head candidate over ABI (ABI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HDSN carries a Unified Composite Score of 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin), whereas ABI carries 52.7/100 (HOLD) at $24.46 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile ABI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 37.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HDSN leads the Growth & Scale pillar: HDSN posts -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin), compared with ABI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HDSN generates $242M in USD-normalized revenue versus N/A for ABI. In operating R&D and SG&A reinvestment, HDSN deploys 19.0% of Rev ($46M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABI.

HDSN screens cheaper on headline valuation multiples. HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin), whereas ABI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HDSN (-0.5% ROE) versus ABI (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk). By comparison, ABI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.